Andreas Busch Biography and Net Worth

Insider of Absci

Andreas Busch, PhD, Chief Innovation Officer is responsible for leading R&D, technical operations, and driving both Absci's internal and partner programs. Dr. Busch brings substantial R&D expertise to Absci's leadership team as a world-renowned leader in drug discovery and has led R&D efforts for some of the globe's top pharma companies including Sanofi, Bayer, and Shire. His leadership has resulted in over 10 commercial drugs starting from bench to FDA approval with several more in late stage clinical development. He holds the title of Extraordinary Professor of Pharmacology at the Johann Wolfgang Goethe-University in Frankfurt, Germany, where he also received his PhD in Pharmacology.

What is Andreas Busch's net worth?: The estimated net worth of Andreas Busch is at least $1.17 million as of March 12th, 2026. Busch owns 421,446 shares of Absci stock worth more than $1,171,620 as of March 27th. This net worth approximation does not reflect any other assets that Busch may own. Learn More about Andreas Busch's net worth.
How do I contact Andreas Busch?: The corporate mailing address for Busch and other Absci executives is , , . Absci can also be reached via phone at 360-949-1041 and via email at [email protected]. Learn More on Andreas Busch's contact information.
Has Andreas Busch been buying or selling shares of Absci?: In the last ninety days, Andreas Busch has bought $229,000.00 of Absci stock. Most recently, on Thursday, March 12th, Andreas Busch bought 100,000 shares of Absci stock. The stock was acquired at an average cost of $2.29 per share, with a total value of $229,000.00. Following the completion of the transaction, the insider now directly owns 421,446 shares of the company's stock, valued at $965,111.34. Learn More on Andreas Busch's trading history.
Who are Absci's active insiders?: Absci's insider roster includes Todd Bedrick (VP), Andreas Busch (Insider), Zachariah Jonasson (Chief Financial Officer & Chief Business Officer), Sarah Korman (General Counsel), Sean Mcclain (Insider), Karen Mcginnis (Director), and Menelas Pangalos (Director). Learn More on Absci's active insiders.
Are insiders buying or selling shares of Absci?: In the last year, Absci insiders bought shares 4 times. They purchased a total of 255,785 shares worth more than $662,788.10. In the last year, insiders at the sold shares 1 times. They sold a total of 26,761 shares worth more than $80,015.39. The most recent insider tranaction occured on March, 12th when insider Andreas Busch bought 100,000 shares worth more than $229,000.00. Insiders at Absci own 10.5% of the company. Learn More about insider trades at Absci.
Information on this page was last updated on 3/12/2026.

Andreas Busch Insider Trading History at Absci

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
3/12/2026	Buy	100,000	$2.29	$229,000.00	421,446
7/28/2025	Buy	50,000	$3.04	$152,000.00	327,264

Andreas Busch Buying and Selling Activity at Absci

Absci Company Overview

Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to create biologics for patients. Its integrated drug creation platform is designed to improve upon traditional biologic drug discovery by using AI to simultaneously optimize multiple drug characteristics that may be important to development and therapeutic benefit. The company was founded in 2011 and is headquartered in Vancouver, Washington.

Today's Range

Now: $2.78

$2.73

$2.96

50 Day Range

MA: $2.77

$2.30

$3.16

2 Week Range

Now: $2.78

$2.01

$5.23

Volume

4,200,475 shs

Average Volume

3,671,176 shs

Market Capitalization

$425.40 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.12